LUXENA Pharmaceuticals, Inc. dedicated to research and development of novel pharmaceutical products, with special focus on dry powder inhalation formulations. Our leading product is now at phase I clinical stage.
We believe that science and rearches not only allow us to better understand the laws of nature, but also give us the power to create a bettler life. We translate the leading technologies to new medical products that treat diseases and extend lives.
We have a well developed formulation platform for systemic inhalation delivery that delivers the APIs into blood circulation through lungs rapidly, efficiently and safely, with excellent aerodynamic performance and pharmacokinetics.
Copyright © 2026 Your Business — 保留所有權利。